Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Shares Outstanding (2017 - 2025)

Akso Health (AHG) has disclosed Shares Outstanding for 3 consecutive years, with -$1.2 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Shares Outstanding changed 0.0% year-over-year to -$1.2 million, compared with a TTM value of -$1.2 million through Mar 2024, changed 0.0%, and an annual FY2024 reading of -$1.2 million, changed 0.0% over the prior year.
  • Shares Outstanding was -$1.2 million for Q1 2024 at Akso Health, down from $69.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $69.8 million in Q1 2022 and bottomed at -$1.2 million in Q1 2024.
  • Average Shares Outstanding over 3 years is $46.1 million, with a median of $69.8 million recorded in 2022.
  • Peak annual rise in Shares Outstanding hit 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
  • Year by year, Shares Outstanding stood at -$1.2 million in 2022, then changed by 0.0% to -$1.2 million in 2023, then changed by 0.0% to -$1.2 million in 2024.
  • Business Quant data shows Shares Outstanding for AHG at -$1.2 million in Q1 2024, -$1.2 million in Q1 2023, and -$1.2 million in Q1 2022.